Mon, Jun 29 · 8:00

The 7th annual Patients as Partners is guided by a dedicated group of advisors from pharma and biotech, patient advocacy and FDA whom meet quarterly to develop the conference agenda. This is the only event that truly demonstrates how to involve patients throughout the entire medicines development life cycle to drive greater efficiencies in clinical research.The program delves deep into patient involvement ideas, strategies and implementation processes that biopharma can utilize in order to help advance patient participation for better clinical outcomes. Each session demonstrates the what, where, when and how to co-create solutions with patients and measure the impact of those initiatives.

Key Topic Areas Include:

- BioPharma Strategies on Applying Patient Engagement Initiatives and Demonstrating Impact

- Direct-to-Patient Clinical Trials Next Milestones and Actions to Get There

- Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development

- Current Efforts for Educating and Raising Awareness in Clinical Trials

- Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials

- Progress on Patient Data Ownership

- Collaborating with Site Partners And CROs to Increase Efficiencies, Provide Greater Access and Value to Patients and Clinical Trials

- Progress on the National Health Council's Patient Engagement Fair Market Value Initiative

- FDA Reports on the Latest Guidance Updates and New Agency Efforts on Patient Engagement


Standard Rate: USD 1895.0
Academia, Non-Profit and Government Rate: USD 947.5

Speakers: Mohammed Ali, Boehringer Ingelheim, Lynne Alston, John-Manuel Andriote, Jimmy Bechtel, Society for Clinical Research Sites, Chip Bell, PhD, Alexandra Berk, MA, Ciitizen, Jeff Borghoff, Meghana Chalasani, Center for Drug Evaluation and Research (CDER), FDA, Zeena Huang Chi, Genentech, Cindy Chmielewski, Luther T Clark, MD, FACC, FACP, Merck, Kim Cohee, Ultragenyx, Vera David, MD, Science 37, Mahasweta (Maha) Dutt, University of Pennsylvania, Leah Fine, Go2 Foundation for Lung Cancer, Aime Franco, PhD, Children’s Hospital of Philadelphia, Kevin Freiert, Salem Oaks, Ken Getz, MBA, Tufts CSDD / CISCRP, Jamie Troil Goldfarb, Evelyn González, Fox Chase Cancer Center, Pablo Graiver, IQVIA, Scott Gray, Clincierge, Barry Greene, Alnylam Pharmaceuticals, Taren Grom, PharmaVOICE, Tammy Guld, Janssen, Pamela Guthrie, Clincierge, Staci Hargraves, Janssen RandD, Tammy Ice, Syneos Health, Karen Jackler, Center for Biologics Evaluation and Research, FDA, Lauren Johnson, ICON Plc, Thomas Klein, Be the Partner, Michael Kopcha, PhD, RPh, FDA, Lisa La Luna, WCG, Vivian Cheng Larsen, MBA, Takeda, Leanne Larson, Parexel, Erem Latif, MBA, Evidera, Wendi Lau, Astellas Pharma, David Leventhal, MBA, Pfizer, Bennett Levitan, MD, PhD, Janssen RandD, Barry Liden, Edwards Lifesciences, Craig Lipset, Pfizer / Clinical Innovation Partners LLC, Desiree Lyon, American Porphyria Foundation (APF), Esther Maloney, Medical Research Network (MRN), Robin Marcus, GlobalCare Clinical Trials, Megan McBride, MPH, Janssen, Jean McCoy, Health Perspectives Group, Alexandra McGregor, PhD, GSK, Sarah McKeown-Cannon, Langland, Marilyn Metcalf, PhD, GSK, Christeen Moburg, Sangamo Therapeutics, Allison Moore, Hereditary Neuropathy Foundation, Maxwell Mulcahy, Alkermes, Brendan O’Neill, Pfizer, Katie O’Neill, Bionical, Tina Aswani Omprakash, Pan Patel, BMS, Michael Poku, MD, MBA, Signify Health, Erica Prowisor, IQVIA, Alexander Pytlarz, PharmD, Infuserve America, Jeanne Regnante, Patient3i / LUNGevity Foundation, Charity Roddy, Biogen, Seth Rotberg, Inspire, Upal Basu Roy, PhD, MPH, LUNGevity, Anindita Saha, Center for Devices and Radiological Health (CDRH), FDA, Lisa Schill, RASopathies Network, Karlin Schroeder, Parkinson’s Foundation, Jessica Scott, MD, JD, Takeda, T.J. Sharpe, Bernadette Siddiqi, Michael J Fox Foundation, Darryl Sleep, MD, Amgen, Abbe Steel, MSc, HealthiVibe, Susan Stein, Agios Pharmaceuticals, Jean Stimola-Sposaro, Sanofi, Michelle Tarver, MD, PhD, Center for Devices and Radiological Health (CDRH), FDA, Pamela Tenaerts, MD, MBA, Clinical Trial Transformation Initiative (CTTI), Michelle Vichnin, MD, Merck, Fran Visco, National Breast Cancer Coalition (NBCC), Joanne Waldstreicher, MD, Johnson and Johnson, Brian Weiss, Carebox Healthcare Solutions, Rob Weker, Mike Wenger, TrialScope, Beth Zaharoff, GSK